CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-15 | Vaishnaw Akshay Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-06-15 | Borisy Alexis Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2017-06-02 | Cox Gerald Frank Chief Medical Officer | Purchase | +4,000 | $14.15 | $57K | 4,000 |
| 2017-06-02 | Nikolic Boris Director | Purchase | +35,000 | $14.07 | $493K | 35,000 |
| 2017-05-30 | Hirsch Andrew Director | Grant or award · Stock Option (right to buy) | +23,076 | 23,076 | ||
| 2017-05-22 | Bitterman Kevin Director | Sale | −1,000,000 | $17.00 | $17.0M | 2,797,144 |
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Option exercise | +1,000 | $0.65 | $650 | 118,788 |
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $26.41 | $26K | 117,788 |
| 2017-03-15 | Glucksmann Alexandra Chief Operating Officer | Option exercise · Stock Option (right to buy) | −1,000 | 30,461 | ||
| 2017-03-01 | Bosley Katrine President and CEO | Grant or award · Stock Option (right to buy) | +312,000 | 312,000 | ||
| 2017-03-01 | Hack Andrew A. F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +92,500 | 92,500 | ||
| 2017-03-01 | Albright Charles Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2017-02-15 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +3,000 | $3.23 | $10K | 3,000 |
| 2017-02-15 | Hack Andrew A. F. Chief Financial Officer | Sale | −3,000 | $19.20 | $58K | 0 |
| 2017-02-15 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,000 | 155,076 | ||
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Option exercise | +6,000 | $0.65 | $4K | 123,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −5,000 | $20.00 | $100K | 118,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $23.48 | $23K | 117,788 |
| 2017-02-15 | Glucksmann Alexandra Chief Operating Officer | Option exercise · Stock Option (right to buy) | −6,000 | 31,461 | ||
| 2017-01-11 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +15,000 | $3.23 | $48K | 15,000 |
Page 24 of 30 · 588 trades